SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System
Crossref DOI link: https://doi.org/10.1007/s00125-017-4301-8
Published Online: 2017-05-12
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fadini, Gian Paolo
Bonora, Benedetta Maria
Avogaro, Angelo
License valid from 2017-05-12